ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,460.48
-0.41%
US Tech 100
19,181.60
-0.43%
Dow Jones
39,118.86
-0.12%
Brent Oil
84.85
0.00%
Bitcoin
61,442.36
0.90%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cellectis SA (CLLS)

  7. Cellectis SA (CLLS) News

CLLS

Cellectis (CLLS)

Cellectis SA
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CLLS
DateTimeSourceHeadlineSymbolCompany
04/09/20212:30AMGlobeNewswire Inc.Cellectis Completes Sale of $47 million through its ATM programNASDAQ:CLLSCellectis SA
03/29/20214:49PMGlobeNewswire Inc.Cellectis Establishes an At-The-Market (ATM) Program on NasdaqNASDAQ:CLLSCellectis SA
03/29/20214:38PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLLSCellectis SA
03/04/20215:14PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CLLSCellectis SA
03/04/20214:52PMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:CLLSCellectis SA
03/04/20214:49PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLLSCellectis SA
03/04/20214:42PMGlobeNewswire Inc.Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2020 Financial ResultsNASDAQ:CLLSCellectis SA
02/25/20214:30PMGlobeNewswire Inc.Cellectis to Hold Fourth Quarter 2020 Earnings Call on Friday, March 5, 2021 at 8:00AM ESTNASDAQ:CLLSCellectis SA
02/16/20213:59PMEdgar (US Regulatory)Schedule 13gNASDAQ:CLLSCellectis SA
02/16/20217:59AMTipRanksCellectis, Cytovia In $760M Partnership To Develop Natural Killer Cells; Stock Pops 9%NASDAQ:CLLSCellectis SA
02/16/20216:32AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLLSCellectis SA
02/12/20212:10PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CLLSCellectis SA
02/08/202110:18AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CLLSCellectis SA
12/29/20209:11AMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:CLLSCellectis SA
12/29/20207:49AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLLSCellectis SA
12/16/20203:00PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLLSCellectis SA
12/15/20208:15PMGlobeNewswire Inc.Cellectis Announces Withdrawal of Follow-On OfferingNASDAQ:CLLSCellectis SA
12/15/20206:28AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CLLSCellectis SA
12/14/20205:13PMEdgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:CLLSCellectis SA
12/14/20204:18PMGlobeNewswire Inc.Cellectis Announces Launch of Follow-On OfferingNASDAQ:CLLSCellectis SA
12/05/20205:00PMGlobeNewswire Inc.Cellectis Reports Preliminary Results from its Phase 1 BALLI-01 Study of UCART22 in R/R Adult B-ALL at American Society of He...NASDAQ:CLLSCellectis SA
11/18/20206:03AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLLSCellectis SA
11/17/20208:00PMGlobeNewswire Inc.FDA Lifts Clinical Hold on MELANI-01 Study Evaluating Cellectis’ Product Candidate UCARTCS1 in Multiple MyelomaNASDAQ:CLLSCellectis SA
11/16/20204:31PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLLSCellectis SA
11/16/20204:30PMGlobeNewswire Inc.Cellectis Appoints Pharma HR Leader Kyung Nam-Wortman as Executive Vice President, Chief Human Resources OfficerNASDAQ:CLLSCellectis SA
11/10/20202:49PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CLLSCellectis SA
11/05/20204:46PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLLSCellectis SA
11/05/20204:34PMGlobeNewswire Inc.Cellectis Provides Business Update and Reports Financial Results for Third Quarter and First Nine Months 2020NASDAQ:CLLSCellectis SA
11/05/20204:19PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLLSCellectis SA
11/04/20209:25AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLLSCellectis SA
 Showing the most relevant articles for your search:NASDAQ:CLLS

Your Recent History

USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
GRST
Ethema Health (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
CYDY
CytoDyn (QB)
COIN
BTCUSD
Bitcoin
USOTC
KEGS
1812 Brewing (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
NASDAQ
FFIE
Faraday Future Intellige...
USOTC
BLEG
Branded Legacy (PK)
USOTC
BIEL
Bioelectronics (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
EMGE
Emergent Health (PK)
NASDAQ
COOP
Mr Cooper
USOTC
SMCE
SMC Entertainment (PK)
NASDAQ
AVXL
Anavex Life Sciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved